FDA Cloning Oversight Is "Tenuous," May Need Augmentation - Rep. Tauzin
Executive Summary
FDA's regulatory authority over reproductive human cloning appears inadequate and should be either bolstered or granted to another federal agency, House Energy & Commerce Committee Chairman Tauzin (R-La.) told a Commerce/Oversight & Investigations Subcommittee hearing on human cloning March 28.